A Cost-Benefit Analysis of the Wisconsin HIV Drug Assistance Program

In this report, La Follette students conduct a cost-benefit analysis on the Wisconsin HIV Drug Assistance Program.

Report PDF


Summary

This reports evaluates feasible cost-saving policies with the most net benefits for the Wisconsin HIV Drug Assistance Program (WI HDAP), which is currently dealing with the risk of decreasing funds and a potential persistent budget deficit. The report recommends that WI HDAP expand insurance application assistance within contracted WI HDAP agencies, producing an estimated $28.8 million in net benefits, with each newly insured client per year generating $25,731 in marginal savings for the program.

Information

  • Course: Cost-Benefit Analysis Public Affairs 881 taught by Morgan Edwards, Fall 2025
  • Authors: Travis Austin, Mufan Chen, Hunter McCormick, Brett Neumann, Morgan Pincombe, and Jessica Preisler
  • Client: The Wisconsin Department of Health Services